With eight months remaining until the 2024 U.S. presidential election, public health priorities in America are increasingly tied to political leadership—a dynamic that shapes everything from healthcare access to medical innovation. While the connection between politics and health is not new, recent policy shifts and public statements have intensified scrutiny over how elected officials influence health outcomes, particularly for vulnerable populations. According to a Kaiser Family Foundation analysis, nearly 40% of Americans report their healthcare decisions are directly impacted by political rhetoric, a figure that has risen sharply since 2020.

The intersection of politics and health has long been a contentious issue, but the stakes feel higher than ever. In April 2004, actor and activist Christopher Reeve—who became a quadriplegic after a horse-riding accident—wrote in a New York Times op-ed that “hope would be determined by politics” in the U.S. His words resonate today as healthcare policy debates dominate election cycles, with candidates framing their visions for medical research funding, drug pricing, and public health infrastructure. The 2024 election, in particular, has seen sharp contrasts in how presidential hopefuls address health equity, vaccine mandates, and the role of federal agencies like the CDC and NIH.

What sets this election apart is the direct link between political messaging and public health behavior. A 2023 study in JAMA found that presidential candidates’ stances on healthcare can influence voter turnout among seniors by up to 12%, while NEJM research shows that partisan health communications can alter vaccination rates by 5–8% in swing states. With the U.S. facing persistent challenges—from rising diabetes rates (affecting 38 million Americans) to opioid-related deaths (over 100,000 annually)—the 2024 election may determine whether these crises are treated as public health priorities or political liabilities.

“What I didn’t expect was that in this country, home of ‘Truth, Justice and the American way,’ hope would be determined by politics.” — Christopher Reeve, April 27, 2004.

— NYT Archives (@NYTArchives) April 27, 2024

Why Public Health Now Hangs in the Balance of the 2024 Election

The 2024 election cycle has already seen healthcare emerge as a defining issue, with candidates offering starkly different visions for the future. Former President Donald Trump, who has proposed expanding Health Savings Accounts (HSAs) and opposing the Affordable Care Act (ACA), has framed healthcare as an individual responsibility rather than a collective good. His administration’s 2017–2020 Medicaid work requirements, which were later blocked by courts, reflected this approach, aiming to reduce enrollment by 7% (per CMS data).

In contrast, President Joe Biden’s administration has prioritized expanding healthcare access, including the Inflation Reduction Act, which caps insulin costs at $35/month for Medicare beneficiaries. The law also allows Medicare to negotiate drug prices—a policy estimated to save $100 billion over a decade by 2031, according to the Congressional Budget Office.

The divide extends to public health emergencies. During the COVID-19 pandemic, the Biden administration’s $1.9 trillion American Rescue Plan included direct payments to Americans and expanded unemployment benefits, while Trump’s 2020 Operation Warp Speed focused on accelerating vaccine development. Critics argue these approaches reflect deeper ideological splits: one prioritizing immediate economic relief, the other scientific innovation.

How Political Messaging Affects Health Behaviors

Beyond policy, political rhetoric itself can alter public health behaviors. Research from the American Psychological Association shows that partisan health communications can lead to vaccine hesitancy, with Republicans 30% more likely to reject COVID-19 vaccines in states where the governor opposed mandates. Similarly, a 2021 NEJM study found that counties with high Trump vote shares in 2020 saw lower flu vaccination rates in 2021, even as cases surged.

The opioid crisis offers another case study. While both parties have acknowledged the epidemic, their solutions differ sharply. The Biden administration’s 2021 National Drug Control Strategy emphasizes harm reduction, including expanded access to naloxone and medication-assisted treatment (MAT). Trump’s 2017 opioid commission, by contrast, focused on law enforcement and border security, framing addiction as a criminal justice issue rather than a public health one.

These differences matter. A 2021 CDC report found that states with stronger harm reduction policies saw 20% lower overdose deaths in 2020 compared to those with stricter drug laws. The election’s outcome could thus determine whether the U.S. shifts toward a health-centered approach or doubles down on punitive measures.

Medical Innovation: Who Gets Funded?

Political leadership also shapes which medical innovations receive funding. The NIH, the world’s largest biomedical research agency, has seen budget fluctuations tied to presidential priorities. Under Trump, NIH funding grew by $2.6 billion (5%) in 2020, with a focus on cancer research and Alzheimer’s. Biden’s 2021 infrastructure bill included $1.5 billion for NIH advanced research projects, while his 2022 overdose response plan allocated $1 billion for opioid research.